Jeffrey I. Weitz

Sol Sherry Distinguished Lecture in Thrombosis Factor XI as a Target for New Anticoagulants

J. Weitz, J. Fredenburgh, Jeffrey I. Weitz, 2022 .

Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS).

H. Büller, A. T. ten Cate‐Hoek, H. Buller, 2015, Thrombosis research.

Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants [version 1; peer review: 2 approved]

J. Fredenburgh, I. Jaffer, M. Huisman, 2022 .

Histidine-Rich Glycoprotein Modulates the Toxic Effects of High-Dose Polyphosphate in Mice

J. Fredenburgh, Rida A. Malik, Jeffrey I. Weitz, 2024, Arteriosclerosis, thrombosis, and vascular biology.

Non-vitamin K antagonist oral anticoagulants: an appeal for consensus on terminology.

A. Camm, G. Lip, J. Halperin, 2014, Chest.

Human platelets contain a pool of free zinc in dense granules

J. Fredenburgh, A. Stafford, N. Vaezzadeh, 2024, Research and practice in thrombosis and haemostasis.